# 124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors.

> **NCT01931488** · PHASE2 · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Parkinson Disease
- Neuroendocrine Tumors

## Interventions

- **OTHER:** MIBG label with I123 or I124
- **DEVICE:** SPECT imaging

## Key facts

- **NCT ID:** NCT01931488
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-08
- **Primary completion:** 2015-01
- **Final completion:** 2016-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01931488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01931488, "124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01931488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*